Eli Lilly is slated to report first-quarter earnings before the bell on Thursday, in one of the most closely watched reports ...

Lilly warns about counterfeit Mounjaro, flags safety risks; Says counterfeit products did not originate from its supply chain ...

Eli Lilly is set to post earnings Thursday morning, with the stock seen potentially sinking to its lowest level in months ...

A crackdown in Gurugram has exposed counterfeit versions of Mounjaro, raising serious concerns about fake diabetes and weight ...

The pair will harness AI to discover and develop recombinases for precise, large-scale gene editing.

Eli Lilly alleged that Empower lured customers away from their brand-name GLP-1 products and toward the pharmacy's ...

The crew heads to the DR and the drama follows! The post Southern Hospitality Season 4 Episode 9 Recap: Drama in the ...

Key dosing differences between Eli Lilly’s Kisunla and Biogen’s Leqembi are about to come to a head in the Alzheimer's market ...

CRISPR Therapeutics proved the strength of its technology a couple of years ago when it won approval for its first product.

Eli Lilly investors will be searching for something they won't find in any first-quarter financial figures reported on ...

Eli Lilly and Co. is taking another step to bolster its genetic medicine portfolio, this time through a $2.25 billion deal ...

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A ...